Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Steven Masson

Honorary Clinical Senior Lecturer

Newcastle University

United Kingdom

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

70%

Clinical Nutrition

20%

Liver Fibrosis

70%

Gastroenterology

50%

Fatty Liver

50%

Alcohol Use

30%

Hepatobiliary Surgery

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

An adaptive-design randomised placebo-controlled trial of baclofen in the treatment of alcohol use disorder in patients with liver cirrhosis (BASIS)

Open Date: 2021-10-01

Close Date: 2025-09-30

Grant: Close

Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study

Open Date: 2018-09-25

Close Date: 2022-06-30

Grant: Close

Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation.

Open Date: 2015-04-01

Close Date: 2021-12-31

Grant: Close

Genetic risk factors for alcoholic cirrhosis - genome-wide case-control study

Open Date: 2011-09-20

Close Date: 2020-06-30

Articles20

Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort

Article Link

Year:

2025

IL-1 Signal Inhibition in Alcohol-Related Hepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial of Canakinumab

Article Link

Year:

2025

UK needs national strategy to tackle alcohol related harms

Article Link

Year:

2025

Women and People From Deprived Areas Are Less Likely to be Assessed for Liver Transplantation for Alcohol-related Liver Disease: Results From a National Study of Transplant Assessments

Article Link

Year:

2025

Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply

Article Link

Year:

2024

Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply

Article Link

Year:

2024

How effective are experienced hepatologists at staging fibrosis using non‐invasive fibrosis tests in patients with metabolic dysfunction‐associated steatotic liver disease?

Article Link

Year:

2024

Randomized trial investigating the utility of a liver tissue transcriptional biomarker in identifying adult liver transplant recipients not requiring maintenance immunosuppression

Article Link

Year:

2024

A polygenic risk score for alcohol-associated cirrhosis among heavy drinkers with European ancestry

Article Link

Year:

2024

Improving survival in alcohol-related hepatitis: what's new?

Article Link

Year:

2023

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 1: compensated cirrhosis

Article Link

Year:

2023

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis

Article Link

Year:

2023

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 3: special circumstances

Article Link

Year:

2023

Where does genetic testing fit in the diagnostic pathway of patients with cryptogenic cirrhosis?

Article Link

Year:

2023

Extra‐hepatic morbidity and mortality in alcohol‐related liver disease: Systematic review and meta‐analysis

Article Link

Year:

2023

In severe alcohol‐related hepatitis, acute kidney injury is prevalent, associated with mortality independent of liver disease severity, and can be predicted using IL‐8 and micro‐RNAs

Article Link

Year:

2023

Deaths from alcohol-related liver disease in the UK: an escalating tragedy.

Article Link

Year:

2022

All-cause and liver-related mortality risk factors in excessive drinkers: Analysis of data from the UK biobank.

Article Link

Year:

2022

Outcomes After Liver Transplantation With Incidental Cholangiocarcinoma.

Article Link

Year:

2022

Restoring cellular magnesium balance through Cyclin M4 protects against acetaminophen-induced liver damage.

Article Link

Year:

2022

Collaborators16

Richard Parker

UNITED KINGDOM

Francesca Fiorentino

King’s College London

UNITED KINGDOM

Nick Murphy

Honorary Reader

University of Birmingham

UNITED KINGDOM

Michael Heneghan

Professor of Hepatology

King's College Hospital

UNITED KINGDOM

james ferguson

University of Birmingham

UNITED KINGDOM

cesar martin

associate proffessor, academic secretary

University of the Basque Country

SPAIN

Maja Thiele

Odense University Hospital

DENMARK

Quentin M. Anstee

Newcastle University

UNITED KINGDOM

Ewan Forrest

Consultant Hepatologist and Honorary Professor

NHS Greater Glasgow and Clyde

UNITED KINGDOM

William Bernal

King's College London

UNITED KINGDOM

Robert Hunter

Clinical Lecturer

University of Edinburgh

UNITED KINGDOM

Neil Halliday

NIHR Clinical Lecturer in Hepatology

University College London

UNITED KINGDOM

Tiebing Liang

Assistant Research Professor

Indiana University School of Medicine

UNITED STATES

Ashwin D. Dhanda

UNITED KINGDOM

Ann Daly

Professor

Newcastle University

UNITED KINGDOM

Alberto Sanchez-Fueyo

King’s College London

UNITED KINGDOM

How do I reach out?

Meet Kite AI